(Q24203883)

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation for weight-concerned women: group vs. individually tailored, dietary, and weight-control follow-up sessions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of phenylpropanolamine on withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion and cognitive behavioral therapy for weight-concerned women smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Randomized controlled trial for behavioral smoking and weight control treatment: effect of concurrent versus sequential intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion for smoking cessation : predictors of successful outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Experimenter-defined quit dates for smoking cessation: adherence improves outcomes for women but not for men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Elevated positive mood: a mixed blessing for abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of bupropion alone and in combination with nicotine gum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion for smokers hospitalized with acute cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The "bupropion for smoking cessation" trial from a family practice perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion for smoking cessation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Participation in a population-based physical activity programme as an aid for smoking cessation: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The efficacy of moderate-intensity exercise as an aid for smoking cessation in women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of exercise counselling as an aid for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Randomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

High-dose nicotine patch therapy. Percentage of replacement and smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Weight change after smoking cessation using variable doses of transdermal nicotine replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Predicting smoking cessation. Who will quit with and without the nicotine patch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of nicotine gum dose by level of nicotine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Long-term effects of nicotine gum on weight gain after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Dose effects of nicotine gum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine lozenge efficacy in light smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Use of more nicotine lozenges leads to better success in quitting smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of a nicotine lozenge for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Randomised controlled trial of nasal nicotine spray in smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Varenicline for smoking cessation in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Varenicline for smoking cessation: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Weight change among participants in a large sample minimal contact smoking relapse prevention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Offer of a weight management program to overweight and obese weight-concerned smokers improves tobacco dependence treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Self-efficacy and motivation to quit during participation in a smoking cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Successful recruitment of minorities into clinical trials: The Kick It at Swope project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Does menthol attenuate the effect of bupropion among African American smokers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effect of bupropion on depression symptoms in a smoking cessation clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Pharmacogenetic investigation of smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Do small lapses predict relapse to smoking behavior under bupropion treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized trial of sertraline as a cessation aid for smokers with a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Influences of mood, depression history, and treatment modality on outcomes in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Psychological intervention and antidepressant treatment in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Extended nortriptyline and psychological treatment for cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of biochemically confirmed smoking cessation on white blood cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effect of bupropion sustained-release on cigarette craving after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of gender on relapse prevention in smokers treated with bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of bupropion in the indigenous Maori population in New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Onset of major depression during treatment for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine patch and paroxetine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Major depression among adolescent smokers undergoing treatment for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized trial of nortriptyline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Heterogeneity in 12-month outcome among female and male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Exercise as an adjunct to nicotine gum in treating tobacco dependence among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one-year results of Project SCRAP-Tobacco

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The effects of exercise and nicotine replacement therapy on smoking rates in women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effects of physical activity as maintenance for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation among inner-city African Americans using the nicotine transdermal patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Predictors of quitting among African American light smokers enrolled in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Baseline characteristics and recruitment strategies in a randomized clinical trial of African-American light smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Pre-cessation nicotine replacement therapy: pragmatic randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine gum treatment before smoking cessation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A comparison of a nicotine sublingual tablet and placebo for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine gum and self-help manuals in smoking cessation: an evaluation in a medical context.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effects of high dose transdermal nicotine replacement in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Efficacy of nicotine patch in smokers with a history of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The Effect of Nicotine, Silver Acetate, and Placebo Chewing Gum on the Cessation of Smoking. The Influence of Smoking Type and Nicotine Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

An investigation of predictors of nicotine abstinence in a smoking cessation treatment study of smokers with a past history of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Adolescent smokers screened for a nicotine replacement treatment trial: correlates of eligibility and enrollment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Cue exposure treatment for smoking relapse prevention: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Randomized clinical trial: effectiveness of the cognitive-behavioral approach and the use of nicotine replacement transdermal patches for smoking cessation among adults in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine-containing chewing gum in smoking cessation: a double blind trial with half year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Precessation treatment with nicotine skin patch facilitates smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Degree of addiction and effectiveness of nicotine gum therapy for smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized trial of smoking cessation interventions in general practice in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Predictors of smoking cessation following physicians' counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized trial of naltrexone for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Rimonabant--a selective CB1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine receptor partial agonists for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Calorie restriction increases cigarette use in adult smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation, lung function, and weight gain: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Weight concerns among male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The prevalence of weight concerns in a smoking abstinence clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Self-perceived smoking motives and their correlates in a general population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation and weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Symptoms of tobacco withdrawal. A replication and extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation at the workplace: 1 year success of short seminars

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine and food deprivation decrease the ability to resist smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Effective techniques in healthy eating and physical activity interventions: a meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Early and late weight gain following smoking cessation in the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Behavioural interventions to prevent weight gain on smoking cessation: a response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Behavioral interventions to promote smoking cessation and prevent weight gain: a reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Nicotine replacement therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Exercise interventions for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking as a weight-control strategy and its relationship to smoking status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking cessation and severity of weight gain in a national cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Interventions for preventing weight gain after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

The influence of weight-related variables on smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

One-year evaluation of three smoking cessation interventions adminidtered by general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Controlled trial of nicotine polacrilex gum with supportive measures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The nicotine inhaler in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Matching high- and low-dependence smokers to self-help treatment with or without nicotine replacement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The use of nicotine chewing gum as an aid to stopping smoking

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

A comparison of psychological and pharmacological treatment in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The use of transdermal nicotine in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Usefulness of physical exercise for maintaining smoking cessation in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Smoking cessation in family practice: the effects of advice and nicotine chewing gum prescription

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Smoking cessation after acute myocardial infarction: the effects of exercise training

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Combination of behavioral smoking cessation with transdermal nicotine substitution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Exercise enhances the maintenance of smoking cessation in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Transdermal nicotine for smoking cessation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine-replacement therapy with use of a transdermal nicotine patch--a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Controlled trial of transdermal nicotine patch in tobacco withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effect of three smoking cessation treatments on nicotine withdrawal in 141 abstinent alcoholic smokers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Comparing participants and nonparticipants in a smoking cessation trial: selection factors associated with general practitioner recruitment activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Smoking cessation with four nicotine replacement regimes in a lung clinic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine gum and behavioral treatment in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Smoking cessation and weight gain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine gum and behavioral treatment: a placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine replacement: effects of postcessation weight gain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Measures of affect and nicotine dependence predict differential response to smoking cessation treatments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Behavior therapy and the transdermal nicotine patch: effects on cessation outcome, affect, and coping.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

How much weight gain occurs following smoking cessation? A comparison of weight gain using both continuous and point prevalence abstinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Are weight concerns predictive of smoking cessation? A prospective analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine patch and self-help video for cigarette smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Weight suppression and weight rebound in ex-smokers treated with fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Influences of gender and weight gain on short-term relapse to smoking in a cessation trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Behavioral treatment for smokers with a history of alcoholism: predictors of successful outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Extended treatment with bupropion SR for cigarette smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention using d-fenfluramine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The physician-delivered smoking intervention project: can short-term interventions produce long-term effects for a general outpatient population?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Correspondence programs for smoking cessation and weight control: a comparison of two strategies in the Minnesota Heart Health Program.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Do heavy smokers benefit from higher dose nicotine patch therapy?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Combined and separate treatment effects of nicotine chewing gum and self-control method

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Lack of efficacy of transdermal nicotine in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Are higher doses of nicotine replacement more effective for smoking cessation?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

REDUCING BIAS IN SYSTEMATIC REVIEWS OF BEHAVIORAL INTERVENTIONS - A RESPONSE TO PARSONS ET AL

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Randomised controlled trial of nicotine chewing-gum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Report by a subcommittee of the Research Committee of the British Thoracic Society

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Placebo controlled trial of nicotine chewing gum in general practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine chewing gum in general practice: effect of follow up appointments.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Helping people to stop smoking: randomised comparison of groups being treated with acupuncture and nicotine gum with control group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effects of behavioral skills training and schedule of nicotine gum administration on smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

A double-blind study evaluating the long-term safety of varenicline for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Weight gain prevention and smoking cessation: cautionary findings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Smoking cessation in women concerned about weight

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

Bupropion SR vs placebo for smoking cessation in health care professionals

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006219.PUB3

7 January 2021

10.1002/14651858.CD006219.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22258966

1 reference

Consolidated OpenCitations Corpus – April 2017